Electronic Decision Aid for Pancreatic Adenocarcinoma
Massachusetts General Hospital, Boston, MA
Targeting 2 different conditionsElectronic Decision Aid +1 moreN/ARecruitingLed by Daniel C. Chung, MDResearch Sponsored by Massachusetts General HospitalEligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Be older than 18 years old
Must not have
Be younger than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Upinitial recorded recommendation/referral for genetic testing until the date of sample collection, assessed up to 6 months
Awards & highlights
No Placebo-Only Group
Study Summary
This trial will compare how effective an electronic decision aid tool is versus a traditional genetic counselor session for people with ovarian or pancreatic cancer.
Eligible Conditions
- Pancreatic Adenocarcinoma
- Ovarian Cancer
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ initial recorded recommendation/referral for genetic testing until the date of sample collection, assessed up to 6 months
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~initial recorded recommendation/referral for genetic testing until the date of sample collection, assessed up to 6 months
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Primary outcome measures
Average change in knowledge survey score
Decisional Conflict Scores
Shared Decision Making Process Scores
Secondary outcome measures
Average Duration of Decision Making Process
Average time between genetic testing recommendation and sample collection
Percentage of participants choosing genetic testing
+1 moreAwards & Highlights
No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.
Trial Design
2Treatment groups
Experimental Treatment
Active Control
Group I: Electronic decision aid armExperimental Treatment1 Intervention
Receive decision aid followed by an appointment with their oncologist.
Group II: Genetic counselor ArmActive Control1 Intervention
Receive pretest counseling with a genetic counselor.
Find a site
Who is running the clinical trial?
Massachusetts General HospitalLead Sponsor
2,814 Previous Clinical Trials
13,564,962 Total Patients Enrolled
National Cancer Institute (NCI)NIH
13,369 Previous Clinical Trials
41,214,915 Total Patients Enrolled
Daniel C. Chung, MDPrincipal Investigator
Massachusetts General HospitalMedia Library
Frequently Asked Questions
These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
How many people are being granted access to this experiment?
"Yes, this is an active trial recruiting 350 patients from 2 sites, as recent as September 28th, 2022."
Answered by AI
What are the goals that investigators hope to achieve with this clinical trial?
"The aim of this study is to compare the average change in knowledge scores among participants after a genetics session. Other outcomes that will be measured include the percentage of participants who choose to get genetic testing after the educational intervention, the ratio of participants who choose the small, intermediate, or broad testing panel, and the average time it takes between being recommended for genetic testing and having a sample collected."
Answered by AI